| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
62,922 |
61,443 |
$17.29M |
| Y7506 |
|
3,319 |
3,147 |
$6.53M |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
2,878 |
2,765 |
$4.10M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,689 |
18,184 |
$4.02M |
| A0425 |
Ground mileage, per statute mile |
3,917 |
3,748 |
$3.27M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,921 |
5,749 |
$3.07M |
| X4011 |
State-specific procedure code |
7,486 |
7,234 |
$2.70M |
| J3490 |
Unclassified drugs |
13,510 |
10,098 |
$2.34M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,462 |
5,304 |
$2.12M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,442 |
3,408 |
$1.86M |
| 80053 |
Comprehensive metabolic panel |
12,374 |
10,996 |
$1.49M |
| 92567 |
|
8,699 |
8,462 |
$1.47M |
| 67311 |
|
691 |
650 |
$1.43M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
8,118 |
8,069 |
$1.17M |
| 85045 |
|
2,797 |
2,519 |
$1.14M |
| 87631 |
|
2,406 |
2,366 |
$1.04M |
| 36415 |
Collection of venous blood by venipuncture |
4,232 |
3,539 |
$1.00M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,457 |
4,347 |
$957K |
| 95782 |
|
179 |
177 |
$948K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,349 |
1,523 |
$695K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
395 |
370 |
$632K |
| 83020 |
|
646 |
473 |
$524K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
168 |
167 |
$510K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,353 |
1,330 |
$453K |
| 95812 |
|
352 |
345 |
$423K |
| 87070 |
|
1,502 |
1,449 |
$334K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,764 |
1,717 |
$306K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
759 |
751 |
$276K |
| 86900 |
|
336 |
289 |
$236K |
| 86901 |
|
336 |
289 |
$235K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,675 |
1,157 |
$234K |
| 71046 |
Radiologic examination, chest; 2 views |
1,593 |
1,498 |
$230K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,063 |
1,059 |
$212K |
| G0378 |
Hospital observation service, per hour |
208 |
190 |
$206K |
| 86850 |
|
295 |
249 |
$203K |
| 92582 |
|
630 |
605 |
$173K |
| 92555 |
|
441 |
431 |
$154K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,850 |
1,823 |
$150K |
| 92556 |
|
372 |
366 |
$141K |
| 76770 |
|
452 |
438 |
$123K |
| 81001 |
|
854 |
818 |
$120K |
| 73100 |
|
1,016 |
802 |
$111K |
| 77073 |
|
871 |
851 |
$110K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,500 |
1,363 |
$109K |
| 82977 |
|
1,577 |
1,214 |
$109K |
| 92552 |
|
207 |
203 |
$104K |
| 84439 |
|
1,321 |
1,194 |
$98K |
| 80076 |
|
315 |
269 |
$94K |
| 83516 |
|
246 |
221 |
$89K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
624 |
545 |
$84K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
82 |
82 |
$81K |
| 82728 |
|
175 |
148 |
$79K |
| 73620 |
|
819 |
592 |
$73K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
169 |
77 |
$70K |
| 73070 |
|
359 |
281 |
$67K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
555 |
544 |
$60K |
| 82784 |
|
445 |
326 |
$59K |
| 92579 |
|
229 |
220 |
$59K |
| 72082 |
|
644 |
625 |
$58K |
| X4006 |
|
37 |
26 |
$53K |
| 72170 |
|
448 |
438 |
$46K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,553 |
2,362 |
$40K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
135 |
134 |
$38K |
| 82570 |
|
314 |
285 |
$37K |
| 84156 |
|
106 |
104 |
$37K |
| 85027 |
|
134 |
123 |
$35K |
| 73090 |
|
296 |
213 |
$34K |
| 71045 |
Radiologic examination, chest; single view |
1,286 |
661 |
$33K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
26 |
26 |
$33K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
39 |
38 |
$30K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
65 |
64 |
$29K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
362 |
357 |
$28K |
| 81003 |
|
1,072 |
1,028 |
$27K |
| 73521 |
|
98 |
89 |
$26K |
| 86902 |
|
43 |
24 |
$26K |
| 97161 |
|
97 |
85 |
$22K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
27 |
27 |
$20K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,427 |
2,251 |
$16K |
| 92585 |
|
12 |
12 |
$15K |
| X4003 |
|
298 |
292 |
$14K |
| 73590 |
|
134 |
108 |
$14K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
74 |
73 |
$13K |
| 86140 |
|
114 |
114 |
$13K |
| 85652 |
|
144 |
142 |
$13K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
13 |
$13K |
| 82248 |
|
463 |
319 |
$12K |
| 73140 |
|
113 |
107 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
23 |
17 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
130 |
128 |
$10K |
| 81025 |
|
224 |
218 |
$10K |
| 80061 |
Lipid panel |
106 |
86 |
$9K |
| 74018 |
|
159 |
110 |
$7K |
| 92587 |
|
13 |
13 |
$6K |
| 87077 |
|
47 |
45 |
$5K |
| 73564 |
|
19 |
15 |
$5K |
| 92557 |
|
12 |
12 |
$4K |
| 80197 |
|
212 |
130 |
$4K |
| 77077 |
|
13 |
13 |
$4K |
| 74019 |
|
24 |
24 |
$4K |
| Y7508 |
|
12 |
12 |
$4K |
| 87536 |
|
30 |
25 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
266 |
207 |
$3K |
| Y7510 |
|
15 |
12 |
$3K |
| 92133 |
|
43 |
43 |
$3K |
| 76000 |
|
24 |
24 |
$3K |
| 92250 |
|
12 |
12 |
$2K |
| 73560 |
|
31 |
26 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
41 |
40 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
40 |
40 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
38 |
38 |
$2K |
| 73610 |
|
14 |
14 |
$2K |
| 73000 |
|
12 |
12 |
$1K |
| 73630 |
|
12 |
12 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
12 |
12 |
$1K |
| 92018 |
|
12 |
12 |
$1K |
| 83735 |
|
235 |
166 |
$1K |
| 86364 |
|
55 |
55 |
$899.53 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24 |
24 |
$850.76 |
| 83690 |
|
143 |
138 |
$811.39 |
| 86360 |
|
13 |
12 |
$722.13 |
| 83880 |
|
14 |
14 |
$580.83 |
| 86359 |
|
13 |
12 |
$580.04 |
| 87205 |
|
54 |
53 |
$316.99 |
| 83655 |
|
14 |
14 |
$275.60 |
| 84100 |
|
199 |
144 |
$228.03 |
| 87075 |
|
14 |
13 |
$176.88 |
| 83550 |
|
24 |
24 |
$166.80 |
| 83540 |
|
24 |
24 |
$139.25 |
| J7140 |
|
21 |
12 |
$127.87 |
| 87184 |
|
12 |
12 |
$120.60 |
| 86592 |
|
12 |
12 |
$92.29 |
| J7510 |
Prednisolone oral, per 5 mg |
32 |
32 |
$53.13 |
| 85610 |
|
15 |
13 |
$36.23 |
| 85660 |
|
34 |
24 |
$34.16 |
| 0000 |
|
20 |
15 |
$0.00 |
| 87102 |
|
12 |
12 |
$0.00 |